The Cigna Group and OpenAI Partner to Enhance Care and Personalized Support for Patients with Complex Conditions
The Cigna Group and OpenAI have announced a collaboration aimed at improving health outcomes and delivering more personalized support to people living with complex health conditions. The collaboration will integrate OpenAI’s advanced reasoning capabilities into selected clinical workflows and customer experiences across The Cigna Group ecosystem, with an initial focus on supporting patients with cancer.
The initiative is designed to help identify emerging patient needs earlier, personalize interactions and strengthen coordination throughout the cancer care journey. It will particularly focus on the periods between physician appointments, when patients may experience treatment side effects, develop new symptoms, have questions about their care or need help navigating available resources.
By combining OpenAI’s artificial intelligence capabilities with The Cigna Group’s clinical expertise, care-management capabilities and integrated healthcare insights, the organizations aim to create more connected and responsive experiences for patients. The collaboration is expected to provide patients with more personalized outreach and direct engagement through The Cigna Group’s existing channels, programs and care experiences.
The companies said the initial work in oncology could eventually serve as a foundation for broader health intelligence capabilities covering a wider range of conditions.
Bringing AI Into Complex Care Journeys
A complex medical diagnosis can create significant challenges for patients and their families. Cancer care, in particular, can involve multiple clinicians, treatment plans, medications, appointments, benefits considerations and supportive services. Patients may also have questions or experience treatment-related concerns between scheduled appointments.
The Cigna Group and OpenAI are seeking to use AI to provide additional support during these points in the healthcare journey.Dr. Amy Flaster, chief medical officer of The Cigna Group, said a complex diagnosis can immediately change a person’s life and create difficult treatment decisions and challenges navigating the healthcare system.
According to Flaster, integrating OpenAI capabilities into The Cigna Group’s healthcare environment is intended to help connect patients with specialized clinicians, resources and support. The goal is to identify issues earlier, provide assistance between physician visits and make complex care experiences easier for patients to navigate.
The initiative reflects a broader effort within healthcare to use artificial intelligence not simply for administrative efficiency, but also to improve how patients interact with healthcare organizations and care teams.
For patients with complex conditions, timely access to relevant information and appropriate support can be particularly important. AI-enabled tools can potentially help identify information that requires attention and support healthcare professionals in determining when additional engagement may be appropriate.
Combining AI Capabilities With Clinical Expertise
The collaboration brings together two different areas of expertise.OpenAI contributes its frontier model capabilities and artificial intelligence technology, while The Cigna Group contributes clinical expertise, care-management capabilities and integrated health information.
The combination is intended to provide a more comprehensive view of individual patient needs. Rather than relying on a single source of information, the new capabilities are designed to consider relevant clinical, pharmacy, behavioral and benefits information within The Cigna Group’s healthcare ecosystem.
This approach could allow care teams to better understand the circumstances surrounding a patient and identify areas where additional support may be appropriate.Katya Andresen, chief data, digital and AI officer at The Cigna Group, said the value of AI extends beyond simply helping organizations work faster. She emphasized the potential for technology to make patient experiences more personalized.
According to Andresen, combining OpenAI’s model capabilities with The Cigna Group’s clinical expertise, healthcare context and ability to connect individuals with care is intended to create a clinical intelligence capability that can anticipate needs, support personalized action and improve patient services over time.The initiative therefore places personalization at the center of the collaboration.
Initial Focus on Cancer Patients
Cancer will be the first major area of focus under the collaboration.Cancer patients can experience complex and changing needs throughout diagnosis and treatment. Treatment side effects, new symptoms, medication questions, emotional concerns and care-navigation issues can emerge at different stages of a patient’s journey.
The new AI-enabled capabilities are intended to help healthcare professionals recognize these needs and determine appropriate next steps.The companies said the initiative will support patients through more personalized outreach and direct engagement. Depending on the situation, this may help patients understand what they should do next, navigate their care and connect with appropriate clinicians, programs and other resources.
The emphasis on support between doctor visits is particularly relevant because many questions and concerns arise outside traditional appointment settings.Instead of waiting until a subsequent appointment to communicate a concern, patients may receive more proactive guidance or be connected to the appropriate support available through The Cigna Group.The technology is intended to complement, rather than replace, the role of healthcare professionals.
AI-Enabled Support for Oncology Nurses and Case Managers
One of the first capabilities being developed through the collaboration will support oncology nurses and case managers working across Accredo Specialty Pharmacy and Cigna Healthcare.These professionals will receive AI-enabled capabilities designed to bring together information from multiple areas of a patient’s healthcare experience.
The information can include clinical data, pharmacy information, behavioral considerations and benefits-related details. Bringing these areas together is intended to create a more complete view of each patient.For oncology nurses and case managers, having a broader understanding of patient circumstances may help inform conversations and identify potential support needs.
The approach also aims to reduce fragmentation in complex care journeys. Patients frequently interact with different healthcare professionals, pharmacies, insurers and support programs. Connecting relevant information across these areas can help care teams better understand what has already occurred and what assistance may be needed next.
The Cigna Group said these capabilities are intended to strengthen the ability of clinical teams to provide personalized support while maintaining human judgment and oversight.
Creating a Continuous Learning Loop
Another important element of the collaboration is the creation of what The Cigna Group describes as a continuous learning loop.Under this approach, information about patient needs can help inform the support provided at different stages of care. Patient responses may include questions they ask, side effects they report, navigation challenges they encounter and their preferred methods of communication.
These interactions can provide additional information about the types of support that patients find useful.Over time, such insights may help inform future guidance and strengthen clinical workflows.The purpose is not simply to provide a single AI-generated response. Instead, the companies envision a system that can learn from interactions and help improve how patients are supported across different stages of their healthcare journeys.
The patient remains at the center of this process, with the technology intended to help clinical and care-management teams better understand evolving needs.
Supporting Patients Between Physician Visits
One of the key opportunities identified by the companies is the period between medical appointments.Healthcare interactions are often concentrated around scheduled visits, but patients’ needs do not necessarily follow appointment schedules. Treatment side effects may develop days after a visit, while questions about medications or next steps can arise at any time.
The collaboration is designed to help address some of these gaps by enabling more proactive engagement.For example, information provided by a patient could help indicate that additional support may be appropriate. The patient could then potentially be directed toward an appropriate clinician, program or resource within The Cigna Group ecosystem.
This approach could make healthcare navigation more continuous rather than limiting support to individual appointments.However, AI-enabled support remains intended to work alongside healthcare professionals. The Cigna Group has emphasized that clinicians remain responsible for patient care and clinical decisions.
Building on Existing AI Initiatives
The new collaboration builds on artificial intelligence and technology initiatives already underway across The Cigna Group.One example is Accredo’s Pharmacy Forward initiative, which is designed to improve medication adherence and accelerate the time to treatment.
Another is Cigna Healthcare’s expansion of personalized care-management capabilities. According to The Cigna Group, this work has been associated with a 42% reduction in avoidable hospital stays among engaged patients.These initiatives provide part of the clinical, operational and data foundation for the company’s broader efforts to deliver proactive and personalized healthcare support.
The collaboration with OpenAI expands this work by introducing additional reasoning capabilities into selected clinical and customer-facing workflows.Rather than treating AI as an isolated technology program, The Cigna Group is positioning the technology within existing healthcare services and care-management infrastructure.
Connecting Clinical, Pharmacy and Behavioral Information
Complex healthcare journeys often involve multiple dimensions of patient needs.Clinical information can provide insight into diagnoses, treatment and symptoms. Pharmacy information can provide visibility into medications and treatment-related activity. Behavioral information may provide additional context about patient needs, while benefits information can help determine what services or resources are available.
Bringing these areas together can provide care teams with a broader understanding of the patient.The Cigna Group and OpenAI intend to use AI capabilities to help process and connect relevant information within appropriate workflows.The objective is to support care teams in identifying potentially important signals and determining where personalized engagement could provide value.The companies have emphasized that this technology is designed to augment clinical expertise rather than replace it.
Responsible AI and Clinical Oversight
Responsible use of artificial intelligence is a central component of the initiative.The Cigna Group said the collaboration operates under its responsible AI, privacy, security and clinical-governance requirements. AI-generated information is subject to appropriate human oversight, while clinicians remain responsible for patient care and clinical decisions.
This distinction is particularly important when AI is used in healthcare environments.AI systems can process large volumes of information and generate recommendations or insights, but clinical decisions require professional judgment and appropriate consideration of individual patient circumstances.
The Cigna Group’s approach therefore places healthcare professionals within the decision-making process.The company also said patient and member information is handled in accordance with applicable privacy, security and regulatory requirements.
According to the announcement, no patient or member data is maintained by OpenAI or used by OpenAI for model training.These safeguards are intended to provide an appropriate framework for deploying AI capabilities within healthcare settings while protecting patient information.
Expanding Health Intelligence Beyond Oncology
Although cancer care represents the initial focus, the companies envision a broader application of the technology.The Cigna Group said the collaboration could eventually create a range of health intelligence capabilities designed to support patients with various health conditions.
This could extend the underlying approach beyond oncology to other areas where patients experience complex treatment journeys, multiple healthcare interactions or ongoing care-management needs.The experience gained from the initial oncology implementation may help inform future applications.
As AI technology develops, healthcare organizations are increasingly examining how advanced models can support clinical teams, improve patient communication and help individuals navigate complicated healthcare systems.The collaboration between The Cigna Group and OpenAI represents an effort to combine those capabilities with an established healthcare infrastructure.
Enhancing the Patient Experience
At its core, the initiative focuses on making healthcare support more responsive to individual patient circumstances.For patients with complex conditions, healthcare can involve numerous decisions and interactions. Personalized support can potentially help patients understand what comes next, identify appropriate resources and connect with healthcare professionals when additional assistance is required.
The collaboration is designed to use AI to support these interactions while maintaining the role of clinical professionals.For The Cigna Group, the initiative also represents an extension of its broader digital and AI strategy.By combining healthcare data and clinical knowledge with advanced AI reasoning capabilities, the company aims to create tools that can identify emerging needs and help teams respond more effectively.
The partnership between The Cigna Group and OpenAI marks another development in the application of artificial intelligence to healthcare.The initial focus on cancer patients provides a specific setting in which the organizations can develop and evaluate AI-enabled support capabilities. Oncology involves complex treatment pathways and frequent interactions among patients, physicians, pharmacies, care managers and other healthcare professionals.
The new capabilities are intended to strengthen connections among these participants while providing patients with more personalized support.The initiative also illustrates how AI can be integrated into existing healthcare operations rather than deployed as a standalone consumer technology.Through clinical workflows, care-management programs and customer experiences, the organizations aim to use AI to identify emerging needs, personalize engagement and connect patients with appropriate resources.
The Cigna Group’s existing AI initiatives provide an operational foundation for this work, while OpenAI contributes advanced model capabilities.As the collaboration develops, the companies expect the underlying health intelligence capabilities to support a broader range of health conditions and patient needs.
The organizations have also made clear that responsible AI principles, privacy protections, security requirements and clinical oversight will remain important components of the effort.Ultimately, the collaboration seeks to combine technology with human clinical expertise to make complex healthcare journeys more connected and easier to navigate. For patients managing cancer and other complex conditions, the intended benefit is more timely support, better coordination and more personalized engagement throughout the course of care.
Source link: https://newsroom.thecignagroup.com/
